Eventide Asset Management’s Insmed INSM Stock Holding History

Eventide Asset Management’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$62.2M	Buy	583,665 +37,355	+7%	+$4.52M	0.83%	34
2026 Q1	$89.3M	Buy	546,310 +62,721	+13%	+$9.64M	1.48%	13
2025 Q4	$84.2M	Sell	483,589 -521,518	-52%	-$95.2M	1.31%	16
2025 Q3	$145M	Sell	1,005,107 -191,387	-16%	-$23.4M	2.38%	5
2025 Q2	$120M	Buy	1,196,494 +14,819	+1%	+$1.13M	2.11%	5
2025 Q1	$90.2M	Buy	1,181,675 +80,682	+7%	+$6.17M	1.8%	8
2024 Q4	$76M	Buy	1,100,993 +194,598	+21%	+$14M	1.38%	18
2024 Q3	$66.2M	Buy	906,395 +231,210	+34%	+$17.1M	1.14%	29
2024 Q2	$45.2M	Buy	675,185 +40,000	+6%	+$1.55M	0.77%	43
2024 Q1	$17.2M	Hold	635,185	–	–	0.27%	102
2023 Q4	$19.7M	Hold	635,185	–	–	0.32%	89
2023 Q3	$16M	Sell	635,185 -276,918	-30%	-$6.33M	0.29%	97
2023 Q2	$19.2M	Hold	912,103	–	–	0.33%	86
2023 Q1	$15.6M	Buy	912,103 +213,690	+31%	+$4.15M	0.29%	97
2022 Q4	$14M	Buy	+698,413	New	+$13.5M	0.28%	94
2016 Q2	–	Sell	-210,000	Closed	-$2.66M	–	132
2016 Q1	$2.66M	Hold	210,000	–	–	0.15%	95
2015 Q4	$3.81M	Buy	210,000 +65,400	+45%	+$1.15M	0.19%	96
2015 Q3	$2.69M	Buy	144,600 +56,000	+63%	+$1.4M	0.16%	92
2015 Q2	$2.16M	Hold	88,600	–	–	0.12%	96
2015 Q1	$1.84M	Hold	88,600	–	–	0.14%	97
2014 Q4	$1.37M	Hold	88,600	–	–	0.15%	91
2014 Q3	$1.16M	Hold	88,600	–	–	0.16%	88
2014 Q2	$1.77M	Buy	88,600 +16,600	+23%	+$246K	0.24%	81
2014 Q1	$1.37M	Buy	72,000 +39,100	+119%	+$743K	0.21%	87
2013 Q4	$560K	Buy	+32,900	New	+$504K	0.17%	77

Other funds holding INSM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Eventide Asset Management's INSM Position: Q2 2026 in Review

Eventide Asset Management increased its Insmed (INSM) stake by 6.8% in Q2 2026, buying an estimated $4.52M and bringing the position to 583,665 shares worth $62.2M. The position accounts for 0.83% of the portfolio, ranked #34.

Eventide Asset Management first reported a position in INSM in Q4 2013 and has held it in 25 quarters since. The position peaked at $145M in Q3 2025. 665 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

Eventide Asset Management held 583,665 shares of Insmed worth $62.2M as of Q2 2026.
Eventide Asset Management bought 37,355 Insmed shares in Q2 2026, an estimated $4.52M.
Insmed made up 0.83% of Eventide Asset Management's portfolio in Q2 2026, its #34 holding.
Eventide Asset Management first reported a position in Insmed in Q4 2013 and has held it in 25 quarters since.
Eventide Asset Management's Insmed position peaked at $145M in Q3 2025.
665 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Eventide Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.